Article
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children
2022-05-21
Abstract excerpt
Currently available mRNA vaccines are extremely safe and effective to prevent severe SARS-CoV-2 infections. However, the emergence of novel variants of concerns has highlighted the importance of high population-based vaccine rates to effectively suppress viral transmission and breakthrough infections. While initially left out from vaccine efforts, children have become one of the most affected age groups and are ke...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 428095eb-4ee5-516e-9e02-9a65d335cdeb
- DOI
- 10.1101/2022.05.18.22275283
